Literature DB >> 18095153

Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia.

Chanel E Smart1, Catherine Clarke, Kelly M Brooks, Ashwini Raghavendra, Brooke L Brewster, Juliet D French, Rehan Hetherington, Jean S Fleming, Joseph A Rothnagel, Brandon Wainwright, Sunil R Lakhani, Melissa A Brown.   

Abstract

Tumours arising in BRCA1 mutation carriers have a characteristic phenotype, the molecular and cellular basis of which is unknown. To address the hypothesis that this phenotype reflects a role for BRCA1 in either in the basal or the stem cell compartments of the mammary epithelia, we have targeted its disruption to K14 and K6a expressing cells of the mouse. Unlike MMTV and WAP driven conditional knockout models of Brca1, these two models did not result in any observable changes in the mammary gland. Our results suggest that BRCA1-associated tumours arise either in K14 and K6a negative basal cells of the mammary gland, or possibly from transdifferentiation of luminal epithelia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095153     DOI: 10.1007/s10549-007-9859-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  2 in total

Review 1.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Dual recombinase action in the normal and neoplastic mammary gland epithelium.

Authors:  Patrick D Rädler; Kerry Vistisen; Aleata A Triplett; Rayane Dennaoui; Yong Li; Hridaya Shrestha; Rosa-Maria Ferraiuolo; Amalraj Thangasamy; Dieter Saur; Kay-Uwe Wagner
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.